These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29569178)

  • 1. The encapsulation of the gemcitabine anticancer drug into grapheme nest: a theoretical study.
    Mlaouah M; Tangour B; El Khalifi M; Gharbi T; Picaud F
    J Mol Model; 2018 Mar; 24(4):102. PubMed ID: 29569178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A density functional theory-based analysis of the structural, topological and electronic properties of gemcitabine drug adsorption on the pyrrolidine functionalized single-walled carbon nanotube.
    Moradnia H; Raissi H; Bakhtiari A
    J Biomol Struct Dyn; 2019 Jul; 37(10):2477-2486. PubMed ID: 30035661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering of gemcitabine coated nano-graphene oxide sheets for efficient near-infrared radiation mediated in vivo lung cancer photothermal therapy.
    Wei X; Li P; Zhou H; Hu X; Liu D; Wu J; Wang Y
    J Photochem Photobiol B; 2021 Mar; 216():112125. PubMed ID: 33601257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of the structural, topological, and electronic properties of the functionalized Graphene nanosheets as potential Tegafur anticancer drug carriers using DFT method.
    Shahabi M; Raissi H
    J Biomol Struct Dyn; 2018 Aug; 36(10):2517-2529. PubMed ID: 28758844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing Two-Dimensional Nanosheets for Improving Drug Delivery to Fucose-Receptor-Overexpressing Cancer Cells.
    Gupta N; Jangid AK; Singh M; Pooja D; Kulhari H
    ChemMedChem; 2018 Dec; 13(24):2644-2652. PubMed ID: 30371024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulation of gemcitabine lipophilic derivatives into polycyanoacrylate nanospheres and nanocapsules.
    Stella B; Arpicco S; Rocco F; Marsaud V; Renoir JM; Cattel L; Couvreur P
    Int J Pharm; 2007 Nov; 344(1-2):71-7. PubMed ID: 17651931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the chitosan-functionalized graphene oxide as a carrier for loading thioguanine, an antitumor drug and effect of urea on adsorption process: Combination of DFT computational and molecular dynamics simulation studies.
    Hasanzade Z; Raissi H
    J Biomol Struct Dyn; 2019 Jul; 37(10):2487-2497. PubMed ID: 30052134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theoretical demonstration of the potentiality of boron nitride nanotubes to encapsulate anticancer molecule.
    El Khalifi M; Duverger E; Gharbi T; Boulahdour H; Picaud F
    Phys Chem Chem Phys; 2015 Nov; 17(44):30057-64. PubMed ID: 26498990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailoring the properties of mPEG-PLLA nanoparticles for better encapsulation and tuned release of the hydrophilic anticancer drug.
    Surwase SS; Munot NM; Idage BB; Idage SB
    Drug Deliv Transl Res; 2017 Jun; 7(3):416-427. PubMed ID: 28324320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the adsorption properties of gemcitabine anticancer drug with metal-doped boron nitride fullerenes as a drug-delivery carrier: a DFT study.
    Bibi S; Ur-Rehman S; Khalid L; Bhatti IA; Bhatti HN; Iqbal J; Bai FQ; Zhang HX
    RSC Adv; 2022 Jan; 12(5):2873-2887. PubMed ID: 35425316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced cellular uptake and intracellular drug controlled release of VESylated gemcitabine prodrug nanocapsules.
    Fang Y; Du F; Xu Y; Meng H; Huang J; Zhang X; Lu W; Liu S; Yu J
    Colloids Surf B Biointerfaces; 2015 Apr; 128():357-362. PubMed ID: 25746328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How do carbon nanotubes serve as carriers for gemcitabine transport in a drug delivery system?
    Arsawang U; Saengsawang O; Rungrotmongkol T; Sornmee P; Wittayanarakul K; Remsungnen T; Hannongbua S
    J Mol Graph Model; 2011 Feb; 29(5):591-6. PubMed ID: 21167762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism for ribonucleotide reductase inactivation by the anticancer drug gemcitabine.
    Pereira S; Fernandes PA; Ramos MJ
    J Comput Chem; 2004 Jul; 25(10):1286-94. PubMed ID: 15139041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theoretical Study on the Aggregation and Adsorption Behaviors of Anticancer Drug Molecules on Graphene/Graphene Oxide Surface.
    Gong P; Zhou Y; Li H; Zhang J; Wu Y; Zheng P; Jiang Y
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical functionalization of graphene via aryne cycloaddition: a theoretical study.
    Zhao JX; Wang HX; Gao B; Wang XG; Cai QH; Wang XZ
    J Mol Model; 2012 Jun; 18(6):2861-8. PubMed ID: 22127614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
    Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
    Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Density functional theory calculations and molecular dynamics simulations of the adsorption of biomolecules on graphene surfaces.
    Qin W; Li X; Bian WW; Fan XJ; Qi JY
    Biomaterials; 2010 Feb; 31(5):1007-16. PubMed ID: 19880174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocompatible Glycopolymer Nanocapsules via Inverse Miniemulsion Periphery RAFT Polymerization for the Delivery of Gemcitabine.
    Utama RH; Jiang Y; Zetterlund PB; Stenzel MH
    Biomacromolecules; 2015 Jul; 16(7):2144-56. PubMed ID: 26027950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and fabrication of dual-targeted delivery system based on gemcitabine-conjugated human serum albumin nanoparticles.
    Norouzi P; Amini M; Mottaghitalab F; Mirzazadeh Tekie FS; Dinarvand R; Mirzaie ZH; Atyabi F
    Chem Biol Drug Des; 2020 Aug; 96(2):745-757. PubMed ID: 28640541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme-responsive peptide dendrimer-gemcitabine conjugate as a controlled-release drug delivery vehicle with enhanced antitumor efficacy.
    Zhang C; Pan D; Li J; Hu J; Bains A; Guys N; Zhu H; Li X; Luo K; Gong Q; Gu Z
    Acta Biomater; 2017 Jun; 55():153-162. PubMed ID: 28259838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.